Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 6—June 2005

Perspective

Antimicrobial Resistance Determinants and Future Control

Stephan Harbarth*Comments to Author  and Matthew H. Samore†
Author affiliations: *University of Geneva Hospitals, Geneva, Switzerland; †VA Salt Lake City Health Care System, Salt Lake City, Utah, USA

Main Article

Figure 2

Number of antimicrobial drug packages sold in the outpatient setting in Chile, 1988–2002. Package is the term used to show sales figures of antimicrobial drugs from wholesalers or pharmacies. It is also used to calculate the number of daily defined doses for each marketed antimicrobial drug. Data are from Bavestrello et al (32). Unpublished data from 2001 and 2002 were provided by A. Cabello Munoz and L. Bavestrello (Viña del Mar, Chile).

Figure 2. . Number of antimicrobial drug packages sold in the outpatient setting in Chile, 1988–2002. Package is the term used to show sales figures of antimicrobial drugs from wholesalers or pharmacies. It is also used to calculate the number of daily defined doses for each marketed antimicrobial drug. Data are from Bavestrello et al (32). Unpublished data from 2001 and 2002 were provided by A. Cabello Munoz and L. Bavestrello (Viña del Mar, Chile).

Main Article

TOP